B-COOL
OSE Immunotherapeutics
Mark For: B-COOL® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88136288 |
| Registration Number | 6383178 |
| Mark Literal Elements | B-COOL |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | SERVICE MARK |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2021-02-23 |
| Basis | 44(e) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | No |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | Yes |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Patrick J. Jennings |
| Attorney Docket Number | 22044-462175 |
| Law Office Assigned | N10 |
| Employee Name | KELLY, JOHN M |
Timeline
| 2018-09-28 | Application Filed |
| 2018-12-15 | Location: TMO LAW OFFICE 119 - EXAMINING ATTORNEY ASSIGNED |
| 2019-01-08 | Status: Live/Pending |
| 2019-01-08 | Transaction Date |
| 2019-12-03 | Trademark Registered |
| 2021-02-23 | Location: PUBLICATION AND ISSUE SECTION |
| 2021-03-30 | Published |
| 2021-03-30 | Status: Application has been published for opposition. The opposition period begins on the date of publication. |
| 2021-06-15 | Trademark Registered |
Trademark Parties (Applicants & Owners)
| Party: |  OSE Immunotherapeutics |
| Address | 22 Boulevard Benoni Goullin Nantes FRANCE 44200 |
| Legal Entity Type | Société Anonyme (sa) |
| Legal Entity State | FRANCE |
Documents
Drawing
TEAS RF New ApplicationAttorney of Record
Good, Services, and Codes
IC 042. US 100 101. G & S: Scientific and technological services, namely, research and design in the field of medicine and health in the field of autoimmune diseases and different types of cancer; Design and development of software and databases in the field of autoimmune diseases and different types of cancer; Medical research in the field of autoimmune diseases and different types of cancer; Biological research in the field of autoimmune diseases and different types of cancer; Biotechnology research in the field of autoimmune diseases and different types of cancer; Pharmaceutical research services in the field of autoimmune diseases and different types of cancer; Clinical research in the field of autoimmune diseases and different types of cancer; Research and development services in the field of immunology in the field of autoimmune diseases and different types of cancer; Research and development in the field of microorganisms, cells and antibodies in the field of autoimmune diseases and different types of cancer; Research and development of vaccines and medicines in the field of autoimmune diseases and different types of cancer; Biological analysis in the field of autoimmune diseases and different types of cancer; Biological laboratory services in the field of autoimmune diseases and different types of cancer; Consultancy relating to research and development in the field of therapy; Laboratory services relating to the production of monoclonal antibodies in the field of autoimmune diseases and different types of cancer; Research and development services in the field of antibodies in the field of autoimmune diseases and different types of cancer
IC 044. US 100 101. G & S: Medical services in the field of autoimmune diseases and different types of cancer; Advice relating to immunology in the field of autoimmune diseases and different types of cancer; therapy services in the nature of therapeutic health care services in the field of autoimmune diseases and different types of cancer
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0441 | Medical services in the field of autoimmune diseases and different types of cancer; Advice relating to immunology in the field of autoimmune diseases and different types of cancer; therapy services in the nature of therapeutic health care services in the field of autoimmune diseases and different types of cancer |
| GS0421 | Scientific and technological services, namely, research and design in the field of medicine and health in the field of autoimmune diseases and different types of cancer; Design and development of software and databases in the field of autoimmune diseases and different types of cancer; Medical research in the field of autoimmune diseases and different types of cancer; Biological research in the field of autoimmune diseases and different types of cancer; Biotechnology research in the field of autoimmune diseases and different types of cancer; Pharmaceutical research services in the field of autoimmune diseases and different types of cancer; Clinical research in the field of autoimmune diseases and different types of cancer; Research and development services in the field of immunology in the field of autoimmune diseases and different types of cancer; Research and development in the field of microorganisms, cells and antibodies in the field of autoimmune diseases and different types of cancer; Research and development of vaccines and medicines in the field of autoimmune diseases and different types of cancer; Biological analysis in the field of autoimmune diseases and different types of cancer; Biological laboratory services in the field of autoimmune diseases and different types of cancer; Consultancy relating to research and development in the field of therapy; Laboratory services relating to the production of monoclonal antibodies in the field of autoimmune diseases and different types of cancer; Research and development services in the field of antibodies in the field of autoimmune diseases and different types of cancer |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| PUBLISHED FOR OPPOSITION | 2021-03-30 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-03-30 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-03-10 | |
| PETITION TO DIRECTOR - CHANGE BASIS - GRANTED | 2021-02-11 | 86882 |
| NOTICE OF ALLOWANCE CANCELLED | 2021-02-11 | 66530 |
| CASE RETURNED TO EXAMINATION | 2021-02-11 | 66530 |
| ASSIGNED TO PETITION STAFF | 2021-02-11 | 86882 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-12-03 | |
| TEAS EXTENSION RECEIVED | 2020-12-01 | |
| EXTENSION 1 GRANTED | 2020-12-01 | 98765 |
| EXTENSION 1 FILED | 2020-12-01 | 98765 |
| TEAS PETITION TO DIRECTOR RECEIVED | 2020-09-09 | 1111 |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2020-06-02 | |
| PUBLISHED FOR OPPOSITION | 2020-04-07 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-04-07 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-03-18 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-02-28 | 88889 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-02-28 | |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-02-27 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-02-27 | 88889 |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-12-05 | 6325 |
| NON-FINAL ACTION WRITTEN | 2019-12-05 | 76071 |
| NON-FINAL ACTION E-MAILED | 2019-12-05 | 6325 |
| LIE CHECKED SUSP - TO ATTY FOR ACTION | 2019-10-07 | 68123 |
| ASSIGNED TO LIE | 2019-09-25 | 68123 |
| SUSPENSION LETTER WRITTEN | 2019-02-28 | 76071 |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2019-02-28 | 6332 |
| LETTER OF SUSPENSION E-MAILED | 2019-02-28 | 6332 |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-01-08 | 88889 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-01-07 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-01-07 | 88889 |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-12-15 | 6325 |
| NON-FINAL ACTION WRITTEN | 2018-12-15 | 76071 |
| NON-FINAL ACTION E-MAILED | 2018-12-15 | 6325 |
| ASSIGNED TO EXAMINER | 2018-12-14 | 76071 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-10-11 | |
| NEW APPLICATION ENTERED IN TRAM | 2018-10-02 |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 